INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
CG

Cota Germaine

SVP, FINANCE & ACCOUNTINGCIK 0001830532

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 0
Max Insider Score21
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
CG
Cota GermaineChief Accting. Off. & VP, Fin.
ALABAstera Labs, Inc.
Grant or award
A—
3,116 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Astera Labs, Inc.Chief Accting. Off. & VP, Fin. · Feb 4, 2026
  • Insider ofevidence
    BILL Holdings, Inc.SVP, FINANCE & ACCOUNTING · Dec 2, 2025
21
CG
Cota GermaineChief Accting. Off. & VP, Fin.
ALABAstera Labs, Inc.
Grant or award
A
—
21.8K sh
Feb 2, 2026
Feb 4, 2026
traded Feb 2, 2026
+2d
SEC FORM 4

Evidence

21
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Option exercise
M—
730 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence

17
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Option exercise
M—
3,726 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence

9
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Option exercise
M—
1,208 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence

13
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Option exercise
M—
261 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence

16
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Tax withholding
F$95K
1,895 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence

13
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Option exercise
M—
1,073 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence

21
CG
Cota GermaineSVP, FINANCE & ACCOUNTING
BILLBILL Holdings, Inc.
Option exercise
M—
454 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC FORM 4

Evidence